The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion
Open accessAbstract
Bone destruction is the most difficult target in the treatment of rheumatoid arthritis (RA). Here, we report that local overexpression of IL-4, introduced by a recombinant human type 5 adenovirus vector (Ad5E1mIL-4) prevents joint damage and bone erosion in the knees of mice with collagen arthritis (CIA). No difference was noted in the course of CIA in the injected knee joints between Ad5E1mIL-4 and the control vector, but radiographic analysis revealed impressive reduction of joint erosion and more compact bone structure in the Ad5E1mIL-4 group. Although severe inflammation persisted in treated mice, Ad5E1mIL-4 prevented bone erosion and diminished tartrate-resistant acid phosphatase (TRAP) activity, indicating that local IL-4 inhibits the formation of osteoclast-like cells. Messenger RNA levels of IL-17, IL-12, and cathepsin K in the synovial tissue were suppressed, as were IL-6 and IL-12 protein production. Osteoprotegerin ligand (OPGL) expression was markedly suppressed by local IL-4, but no loss of OPG expression was noted with Ad5E1mIL-4 treatment. Finally, in in vitro studies, bone samples of patients with arthritis revealed consistent suppression by IL-4 of type I collagen breakdown. IL-4 also enhanced synthesis of type I procollagen, suggesting that it promoted tissue repair. These findings may have significant implications for the prevention of bone erosion in arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Moore, K. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.165 · Cited by 1,884
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,668
Autoimmunity to type II collagen an experimental model of arthritis.
Trentham, D. E., Townes, A. S., & Kang, A. H. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.3.857 · Cited by 1,603
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
IL-6 is produced by osteoblasts and induces bone resorption.
Ishimi, Y., Miyaura, C., Jin, C. H., Akatsu, T., Abe, E., Nakamura, Y., Yamaguchi, A., Yoshiki, S., Matsuda, T., Hirano, T., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3297 · Cited by 1,128
Immunisation against heterologous type II collagen induces arthritis in mice
Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025
Modulation of Osteoclast Differentiation
SUDA, T., TAKAHASHI, N., & MARTIN, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
Dr. Garnero, P., Sornay-Rendu, E., Chapuy, M.-C., & Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110307 · Cited by 1,001
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
Billinghurst, R. C., Dahlberg, L., Ionescu, M., Reiner, A., Bourne, R., Rorabeck, C., Mitchell, P., Hambor, J., Diekmann, O., Tschesche, H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119316 · Cited by 968
Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L., & Miossec, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<963::aid-anr15>3.0.co;2-e · Cited by 954
Self-citationMatrix Metalloproteinase-2 Is an Interstitial Collagenase
Aimes, R. T., & Quigley, J. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.5872 · Cited by 944
Arend, W. P., & Dayer, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380202 · Cited by 891
Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts
Drake, F. H., Dodds, R. A., James, I. E., Connor, J. R., Debouck, C., Richardson, S., Lee-Rykaczewski, E., Coleman, L., Rieman, D., Barthlow, R., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12511 · Cited by 720
Quantitative analysis of cytokine gene expression in rheumatoid arthritis.
Firestein, G. S., Alvaro-Gracia, J. M., & Maki, R. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3347 · Cited by 598
Advances in Bone Biology: The Osteoclast*
ROODMAN, G. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-4-308 · Cited by 549
Gravallese, E. M., Harada, Y., Wang, J. T., Gorn, A. H., Thornhill, T. S., & Goldring, S. R. (1998) · Europe PMC (PubMed Central) · Cited by 516
Guerne, P. A., Zuraw, B. L., Vaughan, J. H., Carson, D. A., & Lotz, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113921 · Cited by 513
(2008) · Arthritis & Rheumatism · doi:10.1002/art.23363 · Cited by 505
Cells of bone: proliferation, differentiation, and hormonal regulation
Nijweide, P. J., Burger, E. H., & Feyen, J. H. (1986) · Physiological Reviews · doi:10.1152/physrev.1986.66.4.855 · Cited by 474
Pfeilschifter, J., Chenu, C., Bird, A., Mundy, G. R., & Roodman, D. G. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040116 · Cited by 468
Joosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., & van den Berg, W. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390513 · Cited by 400
Self-citationJoosten, L. A. B., Lubberts, E., Durez, P., Helsen, M. M. A., Jacobs, M. J. M., Goldman, M., & van den Berg, W. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400209 · Cited by 397
Self-citationLoo, F. A. J. V. D., Joosten, L. A. B., Van Lent, P. L. E. M., Arntz, O. J., & Van Den Berg, W. B. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380204 · Cited by 380
Self-citationLöwik, C. W. G. M., van der Pluijm, G., Bloys, H., Hoekman, K., Bijvoet, O. L. M., Aarden, L. A., & Papapoulos, S. E. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90851-6 · Cited by 373
Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts.
Tezuka, K., Tezuka, Y., Maejima, A., Sato, T., Nemoto, K., Kamioka, H., Hakeda, Y., & Kumegawa, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42227-7 · Cited by 341
Ghivizzani, S. C., Lechman, E. R., Kang, R., Tio, C., Kolls, J., Evans, C. H., & Robbins, P. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4613 · Cited by 287
Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint
Bromley, M., & Woolley, D. E. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270902 · Cited by 277
Th1/Th2 cytokine balance in arthritis
Miossec, P., & Berg, W. V. D. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401203 · Cited by 257
Self-citationde la Mata, J., Uy, H. L., Guise, T. A., Story, B., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117990 · Cited by 255
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment
VAN DEN BERG, W. B., JOOSTEN, L. A. B., HELSEN, M., & VAN DE LOO, F. A. J. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06517.x · Cited by 251
Self-citationAnti-Tumor Necrosis Factor-α Therapy of Rheumatoid Arthritis
Feldmann, M., Elliott, M. J., Maini, R. N., & Woody, J. N. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60891-3 · Cited by 230
Xing, Z., Ohkawara, Y., Jordana, M., Graham, F., & Gauldie, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118503 · Cited by 212
Onoe, Y., Miyaura, C., Kaminakayashiki, T., Nagai, Y., Noguchi, K., Chen, Q. R., Seo, H., Ohta, H., Nozawa, S., Kudo, I., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.2.758 · Cited by 211
Stuart, J. M., Townes, A. S., & Kang, A. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110495 · Cited by 188
Takayanagi, H., Oda, H., Yamamoto, S., Kawaguchi, H., Tanaka, S., Nishikawa, T., & Koshihara, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7404 · Cited by 187
Bakker, A. C., Joosten, L. A. B., Arntz, O. J., Helsen, M. M. A., Bendele, A. M., van de Loo, F. A. J., & van den Berg, W. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400517 · Cited by 186
Self-citationMiossec, P., Briolay, J., Dechanet, J., Wijdenes, J., Martinez‐Valdez, H., & Banchereau, J. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350805 · Cited by 185
Self-citationLubberts, E., Joosten, L. A. B., van den Bersselaar, L., Helsen, M. M. A., Bakker, A. C., van Meurs, J. B. J., Graham, F. L., Richards, C. D., & van den Berg, W. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4546 · Cited by 179
Self-citationSuda, T. (1992) · Endocrine Reviews · doi:10.1210/er.13.1.66 · Cited by 152
Hummel, K. M., Petrow, P. K., Franz, J. K., Müller‐Ladner, U., Aicher, W. K., Gay, R. E., Brömme, D., & Gay, S. (1998) · PubMed · Cited by 148
Bonde, M., Garnero, P., Fledelius, C., Qvist, P., Delmas, P. D., & Christiansen, C. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.7.1028 · Cited by 133
Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.
Hogaboam, C. M., Vallance, B. A., Kumar, A., Addison, C., Graham, F. L., Gauldie, J., & Collins, S. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119823 · Cited by 115
Miossec, P., Chomarat, P., Déchanet‐Merville, J., Moreau, J., Roux, J., Delmas, P. D., & Banchereau, J. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371202 · Cited by 113
Self-citationAn update on interleukin-4 and its receptor.
Chomarat, P., & Banchereau, J. (1997) · PubMed · Cited by 112
Interleukin-4 as a potent inhibitor of bone resorption
Watanabe, K., Tanaka, Y., Morimoto, I., Yahata, K., Zeki, K., Fujihira, T., Yamashita, U., & Eto, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91550-c · Cited by 112
Osteoclast-like cells in murine collagen induced arthritis.
Suzuki, Y., Nishikaku, F., Nakatuka, M., & Koga, Y. (1998) · PubMed · Cited by 86
Garnero, P., Jouvenne, P., Buchs, N., Delmas, P. D., & Miossec, P. (1999) · Bone · doi:10.1016/s8756-3282(98)00193-8 · Cited by 79
Self-citationLubberts, E., Joosten, L. A. B., van den Bersselaar, L., Helsen, M. M., Bakker, A. C., Xing, Z., Richards, C. D., & van den Berg, W. B. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01217.x · Cited by 73
Self-citationMolecular biology of cartilage and bone destruction
ller-Ladner, U. M., Gay, R. E., & Gay, S. (1998) · Current Opinion in Rheumatology · doi:10.1097/00002281-199805000-00010 · Cited by 72
van Meurs, J. B. J., van Lent, P. L. E. M., Singer, I. I., Bayne, E. K., van de Loo, F. A. J., & van den Berg, W. B. (1998) · Arthritis & Rheumatism · Cited by 63
Leisen, J. C. C., Duncan, H., Riddle, J. M., & Pitchford, W. C. (1988) · PubMed · Cited by 63
O'Keefe, R. J., Teot, L. A., Singh, D. R., Puzas, J. E., Rosier, R. N., & Hicks, D. G. (1997) · PubMed · Cited by 58
van Meurs, J. B. J., van Lent, P. L. E. M., Joosten, L. A. B., et al. (1997) · Rheumatology International · doi:10.1007/bf01330296 · Cited by 56
Self-citationInterleukin-4 inhibits bone resorption and acutely increases cytosolic Ca2+ in murine osteoclasts.
Bizzarri, C., Shioi, A., Teitelbaum, S. L., Ohara, J., Harwalkar, V. A., Erdmann, J. M., Lacey, D. L., & Civitelli, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36721-2 · Cited by 45
Increased type I collagen degradation in early rheumatoid arthritis.
Kotaniemi, A., Isomäki, H. A., Hakala, M., et al. (1994) · PubMed · Cited by 20
Cited by
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605
Tesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Interleukin-17 family and IL-17 receptors
Moseley, T. A., Haudenschild, D. R., Rose, L., & Reddi, A. H. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00002-9 · Cited by 918
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Lubberts, E., Koenders, M. I., Oppers‐Walgreen, B., van den Bersselaar, L., Coenen‐de Roo, C. J. J., Joosten, L. A. B., & van den Berg, W. B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20001 · Cited by 709
Self-citation
Metadata
- Authors
- Lubberts, E., Joosten, L. A. B., Chabaud, M., van den Bersselaar, L., Oppers, B., Coenen-de Roo, C. J. J., Richards, C. D., Miossec, P., & van den Berg, W. B.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-06-15
- Volume
- 105
- Issue
- 12
- Pages
- 1697-1710
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2113606609
- Cited by
- 309
- References
- 61
- FWCI
- 16.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.